News
AWH
--
0.00%
--
This Is Why We Think Aspira Women's Health Inc.'s (NASDAQ:AWH) CEO Might Get A Pay Rise Approved By Shareholders
Shareholders will be pleased by the robust performance of Aspira Women's Health Inc. ( NASDAQ:AWH ) recently and this...
Simply Wall St. · 3d ago
Aspira Women's Health Releases Analytical and Initial Clinical Validation Performance for OVASight at ASCO 2021
Aspira Women's Health Inc. (Nasdaq: AWH), a bioanalytical-based women's health company focused on gynecologic disease, released the analytical and initial clinical data for OVASight(TM) in an abstract titled "Serum-based Assay for Adnexal Mass Risk of Ovar...
GlobeNewswire · 06/03 12:00
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.Th...
ACCESSWIRE · 05/27 23:15
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing
, /PRNewswire/ -- BioVaxys Technology Corp. ("BioVaxys" or "the Company") is pleased to announce that , MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A, the Company's ovarian cancer vaccine candidate, and ...
PR Newswire - PRF · 05/24 12:00
REUTERS NEWS SCHEDULE AT 10 a.m. GMT/6 a.m. ET
reuters.com · 05/23 10:00
Aspira Women's Health Inc. to Participate in the William Blair Growth Stock Conference
Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that management will participate in and present at the William Blair Growth Stock Conference on June 1-3, 2021. Details for the event are below:
GlobeNewswire · 05/19 12:00
Parian Global Management LP Buys LendingClub Corp, Aspira Womens Health Inc, Neuronetics Inc, ...
GuruFocus News · 05/17 19:38
UPDATE 1-U.S. Supreme Court takes up case that could limit abortion rights
reuters.com · 05/17 13:43
Is Aspira Women's Health (NASDAQ:AWH) Using Debt In A Risky Way?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Simply Wall St. · 05/15 07:24
Aspira Women's Health, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Aspira Women's Health, Inc. (NASDAQ:AWH) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.
ACCESSWIRE · 05/13 18:30
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Zacks.com · 05/13 16:11
Aspira Women's Health Reports First Quarter 2021 Financial Results
Aspira Women's Health Inc. ("Aspira") (Nasdaq: AWH), a bio-analytical based women's health company focused on gynecologic disease, today reported its financial results for the first quarter ended, March 31, 2021.
GlobeNewswire · 05/13 12:01
Aspira Women's Health to Reveal 3rd Generation Ovarian Cancer Risk Assessment Technology at ASCO 2021
- Analytical and Initial Clinical Validation performance for Aspira's OVASight(TM) blood-based biomarker test for Ovarian Malignancy risk assessment in women with Adnexal Masses.
GlobeNewswire · 05/13 12:00
Aspira Womens Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®
Study Evaluates a 3rd Generation Multivariate Index Assay for serial monitoring women with a benign pelvic mass as well as the expansion of our development of our proteogenomic test for early-stage detection of ovarian cancer in high risk Ovarian Cancer pa...
GlobeNewswire · 05/12 21:05
Aspira Women's Health, Inc. Expands Leadership Team with Industry Veteran
AUSTIN, Texas, May 11, 2021 (GLOBE NEWSWIRE via COMTEX) -- AUSTIN, Texas, May 11, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a...
GlobeNewswire · 05/11 20:05
Earnings Preview: Aspira (AWH) Q1 Earnings Expected to Decline
Zacks.com · 05/06 19:00
Aspira Women’s Health Inc. to Report First Quarter 2021 Financial Results on May 13
AUSTIN, Texas, May 05, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2...
GlobeNewswire · 05/05 12:00
Aspira Womens Health Stock Is Estimated To Be Significantly Overvalued
GuruFocus News · 04/24 07:12
Rugby-Scotland’s Wright out of Women’s Six Nations after red card
reuters.com · 04/06 18:52
A Look At The Fair Value Of Aspira Women's Health Inc. (NASDAQ:AWH)
In this article we are going to estimate the intrinsic value of Aspira Women's Health Inc. ( NASDAQ:AWH ) by projecting...
Simply Wall St. · 03/30 07:00
Webull provides a variety of real-time AWH stock news. You can receive the latest news about Aspira Women`s Health through multiple platforms. This information may help you make smarter investment decisions.
About AWH
Aspira Women’s Health Inc., formerly Vermillion, Inc., is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. The Company sells OVA1, Overa and OVA1PLUS risk of malignancy tests for ovarian cancer. The Company also sells a product for genetic testing for specific women’s health diseases, called ASPiRA GenetiX, with a core focus on ovarian cancer. OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor before planned surgery. The Overa is a second-generation biomarker panel intended to maintain its product’s sensitivity while improving specificity. OVA1PLUS is a service offering combining its OVA1 and Overa products, designed to enhance accuracy and reduce false elevations in the intermediate-risk area.